CTOs on the Move

EXPRAcom Technologies

www.expra.com

 
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.expra.com
  • 4505 boul MíŠtropolitain E E East STE 101 STE 204
    Saint-LíŠonard, QC CAN H1R 1Z4
  • Phone: 514.321.3100

Executives

Name Title Contact Details

Similar Companies

Fisher Software

Fisher Software is a Tampa, FL-based company in the Computers and Electronics sector.

Forward Networks Inc

Forward Networks is transforming the way enterprises design, build, and operate networks.

Black Knight

Black Knight is the industry`s leading provider of technology, data and analytics solutions that facilitate and automate many of the business processes across the mortgage lifecycle. Black Knight offers a premier, end-to-end platform of integrated technology, data and analytics supporting the entire mortgage and home equity loan lifecycle – from origination to servicing to default. Black Knight solutions drive business process automation, workflow, rules and integrated data throughout the loan process, providing a better user experience, cost savings and support for changing regulatory requirements. By integrating lending functions and data, Black Knight helps lenders and servicers reduce risk, improve efficiency and drive financial performance. Black Knight is committed to being a premier business partner that lenders and servicers rely on to achieve their strategic goals, realize greater success and better serve their customers by delivering best-in-class technology, services and insight with a relentless commitment to excellence, innovation, integrity and leadership.

QED National

QED National is a New York, NY-based company in the Computers and Electronics sector.

GNS Healthcare

We solve healthcare`s matching problem. We provide technology, services, and solutions that precisely match health interventions to individuals, helping our clients improve health outcomes and avoid the billions of healthcare dollars wasted on ineffective treatments. By making the precise matching of interventions to individuals possible, we create data-driven evidence to define what works for whom and puts that knowledge within reach for health plans, health systems, biopharmaceutical companies, and foundations and researchers who are working toward improving health outcomes, patient by patient.